Research Programs

 

 

Immunology & Cancer Immunotherapy

Immunotherapy for the treatment of cancer has continued to be a primary focus of the Immunology and Cancer Immunotherapy Research Program.

Focus on Immunology & Cancer Immunotherapy

Profile: Konstantin Dragnev, NCCC's New Associate Director for Clinical Research

As Associate Director for Clinical Research, Dr. Dragnev serves as the fulcrum point between NCCC’s twin missions: advancing cancer research and providing the best possible treatment and care for patients with cancer.

Read more

Co-Directors:
Charles L. Sentman, PhD
Kenneth R. Meehan, MD

The mission of the Program is to create an interdisciplinary environment in which important scientific questions in cancer immunology can be addressed and the development of new immunotherapeutic strategies for the treatment of cancer is facilitated.

The Program achieves this goal by providing resources and activities that foster meaningful interactions among and between basic cancer researchers and clinicians. The Program nurtures these interactions by assisting in the training of young scientists who will pursue careers in the immunology of cancer; by providing forums for the exchange of scientific ideas, and by funding early efforts in translational cancer immunology.